Nabiximols, an oromucosal spray of a whole cannabis plant extract which has a one:one ratio of THC to cannabidiol (CBD), was initially licensed and approved in Europe, the uk, and copyright for the treatment method of pain and spasticity connected to a number of sclerosis (GW Prescribed drugs, 2016; Pertwee, https://accidentliabilitysupport25678.designertoblog.com/64112039/the-2-minute-rule-for-cannabis